Samples for study ST001847
Species: Mus musculus (Factor headings shown in green)
| mb_sample_id | Subject name | Sample name | Facility | Group | Sex | Analysis | Sample_Data:RAW_FILE_NAME | sample volume, µL | observation | Type |
|---|---|---|---|---|---|---|---|---|---|---|
| SA171735 | - | GM138-L | Facility1 | GF | F | Lipids | GM138-L | 150 | - | Plasma + lithium heparin |
| SA171734 | - | GM142-L | Facility1 | GF | F | Lipids | GM142-L | 100 | - | Plasma + lithium heparin |
| SA171736 | - | GM144-L | Facility1 | GF | F | Lipids | GM144-L | 100 | - | Plasma + lithium heparin |
| SA171737 | - | GM146-L | Facility1 | GF | F | Lipids | GM146-L | 150 | - | Plasma + lithium heparin |
| SA171739 | - | GM149-L | Facility1 | GF | F | Lipids | GM149-L | 75 | low volume | Plasma + lithium heparin |
| SA171738 | - | GM76-L | Facility1 | GF | F | Lipids | GM76-L | 100 | - | Plasma + lithium heparin |
| SA171740 | - | GM77-L | Facility1 | GF | F | Lipids | GM77-L | 100 | - | Plasma + lithium heparin |
| SA171744 | - | GM138 | Facility1 | GF | F | Polar | GM138 | 150 | - | Plasma + lithium heparin |
| SA171742 | - | GM142 | Facility1 | GF | F | Polar | GM142 | 100 | - | Plasma + lithium heparin |
| SA171746 | - | GM144 | Facility1 | GF | F | Polar | GM144 | 100 | - | Plasma + lithium heparin |
| SA171743 | - | GM146 | Facility1 | GF | F | Polar | GM146 | 150 | - | Plasma + lithium heparin |
| SA171741 | - | GM149 | Facility1 | GF | F | Polar | GM149 | 75 | - | Plasma + lithium heparin |
| SA171745 | - | GM76 | Facility1 | GF | F | Polar | GM76 | 100 | - | Plasma + lithium heparin |
| SA171747 | - | GM77 | Facility1 | GF | F | Polar | GM77 | 100 | - | Plasma + lithium heparin |
| SA171756 | - | GM139-L | Facility1 | GF | M | Lipids | GM139-L | 150 | - | Plasma + lithium heparin |
| SA171748 | - | GM140-L | Facility1 | GF | M | Lipids | GM140-L | 175 | - | Plasma + lithium heparin |
| SA171749 | - | GM141-L | Facility1 | GF | M | Lipids | GM141-L | 150 | - | Plasma + lithium heparin |
| SA171750 | - | GM143-L | Facility1 | GF | M | Lipids | GM143-L | 25 | low volume | Plasma + lithium heparin |
| SA171751 | - | GM145-L | Facility1 | GF | M | Lipids | GM145-L | 125 | - | Plasma + lithium heparin |
| SA171754 | - | GM147-L | Facility1 | GF | M | Lipids | GM147-L | 125 | - | Plasma + lithium heparin |
| SA171752 | - | GM148-L | Facility1 | GF | M | Lipids | GM148-L | 125 | - | Plasma + lithium heparin |
| SA171753 | - | GM151-L | Facility1 | GF | M | Lipids | GM151-L | 125 | - | Plasma + lithium heparin |
| SA171755 | - | GM78-L | Facility1 | GF | M | Lipids | GM78-L | 100 | - | Plasma + lithium heparin |
| SA171757 | - | GM79-L | Facility1 | GF | M | Lipids | GM79-L | 150 | - | Plasma + lithium heparin |
| SA171763 | - | GM139 | Facility1 | GF | M | Polar | GM139 | 150 | - | Plasma + lithium heparin |
| SA171767 | - | GM140 | Facility1 | GF | M | Polar | GM140 | 175 | - | Plasma + lithium heparin |
| SA171758 | - | GM141 | Facility1 | GF | M | Polar | GM141 | 150 | - | Plasma + lithium heparin |
| SA171766 | - | GM143 | Facility1 | GF | M | Polar | GM143 | 25 | - | Plasma + lithium heparin |
| SA171765 | - | GM145 | Facility1 | GF | M | Polar | GM145 | 125 | - | Plasma + lithium heparin |
| SA171764 | - | GM147 | Facility1 | GF | M | Polar | GM147 | 125 | - | Plasma + lithium heparin |
| SA171759 | - | GM148 | Facility1 | GF | M | Polar | GM148 | 125 | - | Plasma + lithium heparin |
| SA171760 | - | GM151 | Facility1 | GF | M | Polar | GM151 | 125 | - | Plasma + lithium heparin |
| SA171761 | - | GM78 | Facility1 | GF | M | Polar | GM78 | 100 | - | Plasma + lithium heparin |
| SA171762 | - | GM79 | Facility1 | GF | M | Polar | GM79 | 150 | - | Plasma + lithium heparin |
| SA171773 | - | GM122-L | Facility1 | GM15 | F | Lipids | GM122-L | 150 | - | Plasma + lithium heparin |
| SA171776 | - | GM123-L | Facility1 | GM15 | F | Lipids | GM123-L | 150 | - | Plasma + lithium heparin |
| SA171772 | - | GM124-L | Facility1 | GM15 | F | Lipids | GM124-L | 125 | - | Plasma + lithium heparin |
| SA171775 | - | GM127-L | Facility1 | GM15 | F | Lipids | GM127-L | 150 | - | Plasma + lithium heparin |
| SA171774 | - | GM60-L | Facility1 | GM15 | F | Lipids | GM60-L | 150 | - | Plasma + lithium heparin |
| SA171769 | - | GM66-L | Facility1 | GM15 | F | Lipids | GM66-L | 100 | - | Plasma + lithium heparin |
| SA171771 | - | GM68-L | Facility1 | GM15 | F | Lipids | GM68-L | 150 | - | Plasma + lithium heparin |
| SA171768 | - | GM69-L | Facility1 | GM15 | F | Lipids | GM69-L | 100 | - | Plasma + lithium heparin |
| SA171770 | - | GM70-L | Facility1 | GM15 | F | Lipids | GM70-L | 150 | - | Plasma + lithium heparin |
| SA171783 | - | GM122 | Facility1 | GM15 | F | Polar | GM122 | 150 | - | Plasma + lithium heparin |
| SA171782 | - | GM123 | Facility1 | GM15 | F | Polar | GM123 | 150 | - | Plasma + lithium heparin |
| SA171784 | - | GM124 | Facility1 | GM15 | F | Polar | GM124 | 125 | - | Plasma + lithium heparin |
| SA171779 | - | GM127 | Facility1 | GM15 | F | Polar | GM127 | 150 | - | Plasma + lithium heparin |
| SA171778 | - | GM60 | Facility1 | GM15 | F | Polar | GM60 | 150 | - | Plasma + lithium heparin |
| SA171780 | - | GM66 | Facility1 | GM15 | F | Polar | GM66 | 100 | - | Plasma + lithium heparin |
| SA171781 | - | GM68 | Facility1 | GM15 | F | Polar | GM68 | 150 | - | Plasma + lithium heparin |
| SA171777 | - | GM69 | Facility1 | GM15 | F | Polar | GM69 | 100 | - | Plasma + lithium heparin |
| SA171785 | - | GM70 | Facility1 | GM15 | F | Polar | GM70 | 150 | low volume | Plasma + lithium heparin |
| SA171790 | - | GM125-L | Facility1 | GM15 | M | Lipids | GM125-L | 150 | - | Plasma + lithium heparin |
| SA171791 | - | GM126-L | Facility1 | GM15 | M | Lipids | GM126-L | 150 | - | Plasma + lithium heparin |
| SA171788 | - | GM128-L | Facility1 | GM15 | M | Lipids | GM128-L | 150 | - | Plasma + lithium heparin |
| SA171786 | - | GM129-L | Facility1 | GM15 | M | Lipids | GM129-L | 150 | - | Plasma + lithium heparin |
| SA171787 | - | GM130-L | Facility1 | GM15 | M | Lipids | GM130-L | 150 | - | Plasma + lithium heparin |
| SA171792 | - | GM131-L | Facility1 | GM15 | M | Lipids | GM131-L | 150 | - | Plasma + lithium heparin |
| SA171794 | - | GM132-L | Facility1 | GM15 | M | Lipids | GM132-L | 125 | - | Plasma + lithium heparin |
| SA171793 | - | GM61-L | Facility1 | GM15 | M | Lipids | GM61-L | 100 | - | Plasma + lithium heparin |
| SA171795 | - | GM62-L | Facility1 | GM15 | M | Lipids | GM62-L | 100 | - | Plasma + lithium heparin |
| SA171789 | - | GM63-L | Facility1 | GM15 | M | Lipids | GM63-L | 150 | - | Plasma + lithium heparin |
| SA171797 | - | GM71-L | Facility1 | GM15 | M | Lipids | GM71-L | 150 | - | Plasma + lithium heparin |
| SA171796 | - | GM73-L | Facility1 | GM15 | M | Lipids | GM73-L | 100 | - | Plasma + lithium heparin |
| SA171801 | - | GM125 | Facility1 | GM15 | M | Polar | GM125 | 150 | - | Plasma + lithium heparin |
| SA171808 | - | GM126 | Facility1 | GM15 | M | Polar | GM126 | 150 | - | Plasma + lithium heparin |
| SA171804 | - | GM128 | Facility1 | GM15 | M | Polar | GM128 | 150 | - | Plasma + lithium heparin |
| SA171802 | - | GM129 | Facility1 | GM15 | M | Polar | GM129 | 150 | - | Plasma + lithium heparin |
| SA171805 | - | GM130 | Facility1 | GM15 | M | Polar | GM130 | 150 | - | Plasma + lithium heparin |
| SA171807 | - | GM131 | Facility1 | GM15 | M | Polar | GM131 | 150 | - | Plasma + lithium heparin |
| SA171798 | - | GM132 | Facility1 | GM15 | M | Polar | GM132 | 125 | - | Plasma + lithium heparin |
| SA171799 | - | GM61 | Facility1 | GM15 | M | Polar | GM61 | 100 | low volume | Plasma + lithium heparin |
| SA171803 | - | GM62 | Facility1 | GM15 | M | Polar | GM62 | 100 | - | Plasma + lithium heparin |
| SA171806 | - | GM63 | Facility1 | GM15 | M | Polar | GM63 | 150 | - | Plasma + lithium heparin |
| SA171809 | - | GM71 | Facility1 | GM15 | M | Polar | GM71 | 150 | - | Plasma + lithium heparin |
| SA171800 | - | GM73 | Facility1 | GM15 | M | Polar | GM73 | 100 | - | Plasma + lithium heparin |
| SA171818 | - | GM100-L | Facility1 | SOPF | F | Lipids | GM100-L | 150 | - | Plasma + lithium heparin |
| SA171810 | - | GM101-L | Facility1 | SOPF | F | Lipids | GM101-L | 150 | - | Plasma + lithium heparin |
| SA171819 | - | GM102-L | Facility1 | SOPF | F | Lipids | GM102-L | 100 | - | Plasma + lithium heparin |
| SA171815 | - | GM104-L | Facility1 | SOPF | F | Lipids | GM104-L | 150 | - | Plasma + lithium heparin |
| SA171814 | - | GM105-L | Facility1 | SOPF | F | Lipids | GM105-L | 110 | - | Plasma + lithium heparin |
| SA171811 | - | GM106-L | Facility1 | SOPF | F | Lipids | GM106-L | 125 | - | Plasma + lithium heparin |
| SA171813 | - | GM118-L | Facility1 | SOPF | F | Lipids | GM118-L | 150 | - | Plasma + lithium heparin |
| SA171812 | - | GM119-L | Facility1 | SOPF | F | Lipids | GM119-L | 150 | - | Plasma + lithium heparin |
| SA171816 | - | GM98-L | Facility1 | SOPF | F | Lipids | GM98-L | 150 | - | Plasma + lithium heparin |
| SA171817 | - | GM99-L | Facility1 | SOPF | F | Lipids | GM99-L | 100 | - | Plasma + lithium heparin |
| SA171820 | - | GM100 | Facility1 | SOPF | F | Polar | GM100 | 150 | - | Plasma + lithium heparin |
| SA171825 | - | GM101 | Facility1 | SOPF | F | Polar | GM101 | 150 | - | Plasma + lithium heparin |
| SA171829 | - | GM102 | Facility1 | SOPF | F | Polar | GM102 | 100 | - | Plasma + lithium heparin |
| SA171827 | - | GM104 | Facility1 | SOPF | F | Polar | GM104 | 150 | - | Plasma + lithium heparin |
| SA171828 | - | GM105 | Facility1 | SOPF | F | Polar | GM105 | 110 | - | Plasma + lithium heparin |
| SA171821 | - | GM106 | Facility1 | SOPF | F | Polar | GM106 | 125 | - | Plasma + lithium heparin |
| SA171823 | - | GM118 | Facility1 | SOPF | F | Polar | GM118 | 150 | - | Plasma + lithium heparin |
| SA171822 | - | GM119 | Facility1 | SOPF | F | Polar | GM119 | 150 | - | Plasma + lithium heparin |
| SA171826 | - | GM98 | Facility1 | SOPF | F | Polar | GM98 | 150 | - | Plasma + lithium heparin |
| SA171824 | - | GM99 | Facility1 | SOPF | F | Polar | GM99 | 100 | - | Plasma + lithium heparin |
| SA171834 | - | GM107-L | Facility1 | SOPF | M | Lipids | GM107-L | 150 | - | Plasma + lithium heparin |
| SA171833 | - | GM108-L | Facility1 | SOPF | M | Lipids | GM108-L | 150 | - | Plasma + lithium heparin |
| SA171832 | - | GM109-L | Facility1 | SOPF | M | Lipids | GM109-L | 125 | - | Plasma + lithium heparin |
| SA171831 | - | GM110-L | Facility1 | SOPF | M | Lipids | GM110-L | 150 | - | Plasma + lithium heparin |
| SA171836 | - | GM111-L | Facility1 | SOPF | M | Lipids | GM111-L | 150 | - | Plasma + lithium heparin |
| SA171838 | - | GM85-L | Facility1 | SOPF | M | Lipids | GM85-L | 100 | - | Plasma + lithium heparin |
| SA171839 | - | GM91-L | Facility1 | SOPF | M | Lipids | GM91-L | 150 | - | Plasma + lithium heparin |
| SA171837 | - | GM92-L | Facility1 | SOPF | M | Lipids | GM92-L | 100 | - | Plasma + lithium heparin |
| SA171830 | - | GM93-L | Facility1 | SOPF | M | Lipids | GM93-L | 150 | - | Plasma + lithium heparin |
| SA171835 | - | GM95-L | Facility1 | SOPF | M | Lipids | GM95-L | 150 | - | Plasma + lithium heparin |
| SA171845 | - | GM107 | Facility1 | SOPF | M | Polar | GM107 | 150 | - | Plasma + lithium heparin |
| SA171844 | - | GM108 | Facility1 | SOPF | M | Polar | GM108 | 150 | - | Plasma + lithium heparin |
| SA171846 | - | GM109 | Facility1 | SOPF | M | Polar | GM109 | 125 | - | Plasma + lithium heparin |
| SA171843 | - | GM110 | Facility1 | SOPF | M | Polar | GM110 | 150 | - | Plasma + lithium heparin |
| SA171848 | - | GM111 | Facility1 | SOPF | M | Polar | GM111 | 150 | - | Plasma + lithium heparin |
| SA171849 | - | GM85 | Facility1 | SOPF | M | Polar | GM85 | 100 | - | Plasma + lithium heparin |
| SA171847 | - | GM91 | Facility1 | SOPF | M | Polar | GM91 | 150 | - | Plasma + lithium heparin |
| SA171842 | - | GM92 | Facility1 | SOPF | M | Polar | GM92 | 100 | - | Plasma + lithium heparin |
| SA171840 | - | GM93 | Facility1 | SOPF | M | Polar | GM93 | 150 | - | Plasma + lithium heparin |
| SA171841 | - | GM95 | Facility1 | SOPF | M | Polar | GM95 | 150 | - | Plasma + lithium heparin |
| SA171857 | - | GM15_3F_091120_1_L | Facility2 | GM15 | F | Lipids | GM15_3F_091120_1_L | 100 | - | Plasma + lithium heparin |
| SA171855 | - | GM15_3F_091120_2_L | Facility2 | GM15 | F | Lipids | GM15_3F_091120_2_L | 100 | - | Plasma + lithium heparin |
| SA171851 | - | GM15_3F_091120_3_L | Facility2 | GM15 | F | Lipids | GM15_3F_091120_3_L | 100 | - | Plasma + lithium heparin |
| SA171858 | - | GM15_F_261020_1_L | Facility2 | GM15 | F | Lipids | GM15_F_261020_1_L | 100 | - | Plasma + lithium heparin |
| SA171854 | - | GM15_F_261020_2_L | Facility2 | GM15 | F | Lipids | GM15_F_261020_2_L | 66,2 | low volume | Plasma + lithium heparin |
| SA171853 | - | GM15_F_261020_3_L | Facility2 | GM15 | F | Lipids | GM15_F_261020_3_L | 100 | - | Plasma + lithium heparin |
| SA171856 | - | GM15_F_261020_4_L | Facility2 | GM15 | F | Lipids | GM15_F_261020_4_L | 100 | - | Plasma + lithium heparin |
| SA171852 | - | GM15_F_301020_1_L | Facility2 | GM15 | F | Lipids | GM15_F_301020_1_L | 100 | - | Plasma + lithium heparin |
| SA171850 | - | GM15_F_301020_2_L | Facility2 | GM15 | F | Lipids | GM15_F_301020_2_L | 100 | - | Plasma + lithium heparin |
| SA171865 | - | GM15_3F_091120_1 | Facility2 | GM15 | F | Polar | GM15_3F_091120_1 | 100 | - | Plasma + lithium heparin |
| SA171866 | - | GM15_3F_091120_2 | Facility2 | GM15 | F | Polar | GM15_3F_091120_2 | 100 | - | Plasma + lithium heparin |
| SA171863 | - | GM15_3F_091120_3 | Facility2 | GM15 | F | Polar | GM15_3F_091120_3 | 100 | - | Plasma + lithium heparin |
| SA171859 | - | GM15_F_261020_1 | Facility2 | GM15 | F | Polar | GM15_F_261020_1 | 100 | - | Plasma + lithium heparin |
| SA171860 | - | GM15_F_261020_2 | Facility2 | GM15 | F | Polar | GM15_F_261020_2 | 66,2 | low volume | Plasma + lithium heparin |
| SA171861 | - | GM15_F_261020_3 | Facility2 | GM15 | F | Polar | GM15_F_261020_3 | 100 | - | Plasma + lithium heparin |
| SA171864 | - | GM15_F_261020_4 | Facility2 | GM15 | F | Polar | GM15_F_261020_4 | 100 | - | Plasma + lithium heparin |
| SA171867 | - | GM15_F_301020_1 | Facility2 | GM15 | F | Polar | GM15_F_301020_1 | 100 | - | Plasma + lithium heparin |
| SA171862 | - | GM15_F_301020_2 | Facility2 | GM15 | F | Polar | GM15_F_301020_2 | 100 | - | Plasma + lithium heparin |
| SA171876 | - | GM15_2M_081220_1_L | Facility2 | GM15 | M | Lipids | GM15_2M_081220_1_L | 100 | failure of sample prep | Plasma + lithium heparin |
| SA171875 | - | GM15_2M_081220_2_L | Facility2 | GM15 | M | Lipids | GM15_2M_081220_2_L | 100 | - | Plasma + lithium heparin |
| SA171873 | - | GM15_2M_081220_3_L | Facility2 | GM15 | M | Lipids | GM15_2M_081220_3_L | 100 | - | Plasma + lithium heparin |
| SA171869 | - | GM15_2M_081220_4_L | Facility2 | GM15 | M | Lipids | GM15_2M_081220_4_L | 100 | - | Plasma + lithium heparin |
| SA171868 | - | GM15_2Mfin_150121_1_L | Facility2 | GM15 | M | Lipids | GM15_2Mfin_150121_1_L | 100 | - | Plasma + lithium heparin |
| SA171870 | - | GM15_2Mfin_150121_2_L | Facility2 | GM15 | M | Lipids | GM15_2Mfin_150121_2_L | 100 | - | Plasma + lithium heparin |
| SA171874 | - | GM15_M_301020_1_L | Facility2 | GM15 | M | Lipids | GM15_M_301020_1_L | 100 | - | Plasma + lithium heparin |
| SA171871 | - | GM15_M_301020_2_L | Facility2 | GM15 | M | Lipids | GM15_M_301020_2_L | 100 | - | Plasma + lithium heparin |
| SA171872 | - | GM15_M_301020_3_L | Facility2 | GM15 | M | Lipids | GM15_M_301020_3_L | 95 | low volume | Plasma + lithium heparin |
| SA171884 | - | GM15_2M_081220_1 | Facility2 | GM15 | M | Polar | GM15_2M_081220_1 | 100 | failure of sample prep | Plasma + lithium heparin |
| SA171879 | - | GM15_2M_081220_2 | Facility2 | GM15 | M | Polar | GM15_2M_081220_2 | 100 | - | Plasma + lithium heparin |
| SA171878 | - | GM15_2M_081220_3 | Facility2 | GM15 | M | Polar | GM15_2M_081220_3 | 100 | - | Plasma + lithium heparin |
| SA171877 | - | GM15_2M_081220_4 | Facility2 | GM15 | M | Polar | GM15_2M_081220_4 | 100 | - | Plasma + lithium heparin |
| SA171885 | - | GM15_2Mfin_150121_1 | Facility2 | GM15 | M | Polar | GM15_2Mfin_150121_1 | 100 | - | Plasma + lithium heparin |
| SA171883 | - | GM15_2Mfin_150121_2 | Facility2 | GM15 | M | Polar | GM15_2Mfin_150121_2 | 100 | - | Plasma + lithium heparin |
| SA171880 | - | GM15_M_301020_1 | Facility2 | GM15 | M | Polar | GM15_M_301020_1 | 100 | - | Plasma + lithium heparin |
| SA171881 | - | GM15_M_301020_2 | Facility2 | GM15 | M | Polar | GM15_M_301020_2 | 100 | - | Plasma + lithium heparin |
| SA171882 | - | GM15_M_301020_3 | Facility2 | GM15 | M | Polar | GM15_M_301020_3 | 95 | low volume | Plasma + lithium heparin |
| SA171894 | - | oMM12_F_261020_1_L | Facility2 | Oligo-MM12 | F | Lipids | oMM12_F_261020_1_L | 75,2 | low volume | Plasma + lithium heparin |
| SA171888 | - | oMM12_F_261020_2_L | Facility2 | Oligo-MM12 | F | Lipids | oMM12_F_261020_2_L | 100 | - | Plasma + lithium heparin |
| SA171887 | - | oMM12_F_261020_3_L | Facility2 | Oligo-MM12 | F | Lipids | oMM12_F_261020_3_L | 90 | low volume | Plasma + lithium heparin |
| SA171886 | - | oMM12_F_261020_4_L | Facility2 | Oligo-MM12 | F | Lipids | oMM12_F_261020_4_L | 100 | - | Plasma + lithium heparin |
| SA171889 | - | oMM12_F_261020_5_L | Facility2 | Oligo-MM12 | F | Lipids | oMM12_F_261020_5_L | 100 | - | Plasma + lithium heparin |
| SA171890 | - | oMM12_F_261020_6_L | Facility2 | Oligo-MM12 | F | Lipids | oMM12_F_261020_6_L | 60 | low volume | Plasma + lithium heparin |
| SA171893 | - | oMM12_F_261020_7_L | Facility2 | Oligo-MM12 | F | Lipids | oMM12_F_261020_7_L | 100 | - | Plasma + lithium heparin |
| SA171892 | - | oMM12_F_261020_8_L | Facility2 | Oligo-MM12 | F | Lipids | oMM12_F_261020_8_L | 100 | - | Plasma + lithium heparin |
| SA171891 | - | oMM12_F_261020_9_L | Facility2 | Oligo-MM12 | F | Lipids | oMM12_F_261020_9_L | 100 | - | Plasma + lithium heparin |
| SA171895 | - | oMM12_F_261020_1 | Facility2 | Oligo-MM12 | F | Polar | oMM12_F_261020_1 | 75,2 | low volume | Plasma + lithium heparin |
| SA171902 | - | oMM12_F_261020_2 | Facility2 | Oligo-MM12 | F | Polar | oMM12_F_261020_2 | 100 | - | Plasma + lithium heparin |
| SA171903 | - | oMM12_F_261020_3 | Facility2 | Oligo-MM12 | F | Polar | oMM12_F_261020_3 | 90 | low volume | Plasma + lithium heparin |
| SA171900 | - | oMM12_F_261020_4 | Facility2 | Oligo-MM12 | F | Polar | oMM12_F_261020_4 | 100 | - | Plasma + lithium heparin |
| SA171899 | - | oMM12_F_261020_5 | Facility2 | Oligo-MM12 | F | Polar | oMM12_F_261020_5 | 100 | - | Plasma + lithium heparin |
| SA171896 | - | oMM12_F_261020_6 | Facility2 | Oligo-MM12 | F | Polar | oMM12_F_261020_6 | 60 | low volume | Plasma + lithium heparin |
| SA171897 | - | oMM12_F_261020_7 | Facility2 | Oligo-MM12 | F | Polar | oMM12_F_261020_7 | 100 | - | Plasma + lithium heparin |
| SA171898 | - | oMM12_F_261020_8 | Facility2 | Oligo-MM12 | F | Polar | oMM12_F_261020_8 | 100 | - | Plasma + lithium heparin |
| SA171901 | - | oMM12_F_261020_9 | Facility2 | Oligo-MM12 | F | Polar | oMM12_F_261020_9 | 100 | - | Plasma + lithium heparin |
| SA171909 | - | oMM12_2M_271120_1_L | Facility2 | Oligo-MM12 | M | Lipids | oMM12_2M_271120_1_L | 100 | - | Plasma + lithium heparin |
| SA171910 | - | oMM12_2M_271120_2_L | Facility2 | Oligo-MM12 | M | Lipids | oMM12_2M_271120_2_L | 100 | - | Plasma + lithium heparin |
| SA171906 | - | oMM12_4Mfin_040121_1_L | Facility2 | Oligo-MM12 | M | Lipids | oMM12_4Mfin_040121_1_L | 100 | - | Plasma + lithium heparin |
| SA171907 | - | oMM12_4Mfin_040121_2_L | Facility2 | Oligo-MM12 | M | Lipids | oMM12_4Mfin_040121_2_L | 100 | - | Plasma + lithium heparin |
| SA171911 | - | oMM12_4Mfin_040121_3_L | Facility2 | Oligo-MM12 | M | Lipids | oMM12_4Mfin_040121_3_L | 100 | - | Plasma + lithium heparin |
| SA171908 | - | oMM12_4Mfin_040121_4_L | Facility2 | Oligo-MM12 | M | Lipids | oMM12_4Mfin_040121_4_L | 100 | - | Plasma + lithium heparin |
| SA171904 | - | oMM12_M_261020_1_L | Facility2 | Oligo-MM12 | M | Lipids | oMM12_M_261020_1_L | 100 | - | Plasma + lithium heparin |
| SA171905 | - | oMM12_M_261020_2_L | Facility2 | Oligo-MM12 | M | Lipids | oMM12_M_261020_2_L | 85 | low volume | Plasma + lithium heparin |
| SA171914 | - | oMM12_2M_271120_1 | Facility2 | Oligo-MM12 | M | Polar | oMM12_2M_271120_1 | 100 | - | Plasma + lithium heparin |
| SA171918 | - | oMM12_2M_271120_2 | Facility2 | Oligo-MM12 | M | Polar | oMM12_2M_271120_2 | 100 | - | Plasma + lithium heparin |
| SA171912 | - | oMM12_4Mfin_040121_1 | Facility2 | Oligo-MM12 | M | Polar | oMM12_4Mfin_040121_1 | 100 | - | Plasma + lithium heparin |
| SA171913 | - | oMM12_4Mfin_040121_2 | Facility2 | Oligo-MM12 | M | Polar | oMM12_4Mfin_040121_2 | 100 | - | Plasma + lithium heparin |
| SA171915 | - | oMM12_4Mfin_040121_3 | Facility2 | Oligo-MM12 | M | Polar | oMM12_4Mfin_040121_3 | 100 | - | Plasma + lithium heparin |
| SA171919 | - | oMM12_4Mfin_040121_4 | Facility2 | Oligo-MM12 | M | Polar | oMM12_4Mfin_040121_4 | 100 | - | Plasma + lithium heparin |
| SA171917 | - | oMM12_M_261020_1 | Facility2 | Oligo-MM12 | M | Polar | oMM12_M_261020_1 | 100 | - | Plasma + lithium heparin |
| SA171916 | - | oMM12_M_261020_2 | Facility2 | Oligo-MM12 | M | Polar | oMM12_M_261020_2 | 85 | low volume | Plasma + lithium heparin |
| SA171927 | - | CV_F_041120_1_L | Facility2 | SPF | F | Lipids | CV_F_041120_1_L | 100 | - | Plasma + lithium heparin |
| SA171928 | - | CV_F_041120_2_L | Facility2 | SPF | F | Lipids | CV_F_041120_2_L | 100 | - | Plasma + lithium heparin |
| SA171929 | - | CV_F_041120_3_L | Facility2 | SPF | F | Lipids | CV_F_041120_3_L | 100 | - | Plasma + lithium heparin |
| SA171930 | - | CV_F_041120_4_L | Facility2 | SPF | F | Lipids | CV_F_041120_4_L | 91,6 | low volume | Plasma + lithium heparin |
| SA171926 | - | CV_F_271020_1_L | Facility2 | SPF | F | Lipids | CV_F_271020_1_L | 100 | - | Plasma + lithium heparin |
| SA171925 | - | CV_F_271020_2_L | Facility2 | SPF | F | Lipids | CV_F_271020_2_L | 100 | - | Plasma + lithium heparin |
| SA171921 | - | CV_F_271020_3_L | Facility2 | SPF | F | Lipids | CV_F_271020_3_L | 100 | - | Plasma + lithium heparin |
| SA171920 | - | CV_F_271020_4_L | Facility2 | SPF | F | Lipids | CV_F_271020_4_L | 100 | - | Plasma + lithium heparin |
| SA171922 | - | CV_F_271020_5_L | Facility2 | SPF | F | Lipids | CV_F_271020_5_L | 100 | - | Plasma + lithium heparin |
| SA171923 | - | CV_F_271020_6_L | Facility2 | SPF | F | Lipids | CV_F_271020_6_L | 100 | - | Plasma + lithium heparin |
| SA171924 | - | CV_F_271020_7_L | Facility2 | SPF | F | Lipids | CV_F_271020_7_L | 100 | - | Plasma + lithium heparin |
| SA171931 | - | CV_F_271020_8_L | Facility2 | SPF | F | Lipids | CV_F_271020_8_L | 100 | - | Plasma + lithium heparin |
| SA171939 | - | CV_F_041120_1 | Facility2 | SPF | F | Polar | CV_F_041120_1 | 100 | - | Plasma + lithium heparin |
| SA171940 | - | CV_F_041120_2 | Facility2 | SPF | F | Polar | CV_F_041120_2 | 100 | - | Plasma + lithium heparin |
| SA171941 | - | CV_F_041120_3 | Facility2 | SPF | F | Polar | CV_F_041120_3 | 100 | - | Plasma + lithium heparin |
| SA171942 | - | CV_F_041120_4 | Facility2 | SPF | F | Polar | CV_F_041120_4 | 91,6 | low volume | Plasma + lithium heparin |
| SA171938 | - | CV_F_271020_1 | Facility2 | SPF | F | Polar | CV_F_271020_1 | 100 | - | Plasma + lithium heparin |
| SA171937 | - | CV_F_271020_2 | Facility2 | SPF | F | Polar | CV_F_271020_2 | 100 | - | Plasma + lithium heparin |
| SA171933 | - | CV_F_271020_3 | Facility2 | SPF | F | Polar | CV_F_271020_3 | 100 | - | Plasma + lithium heparin |
| SA171934 | - | CV_F_271020_4 | Facility2 | SPF | F | Polar | CV_F_271020_4 | 100 | - | Plasma + lithium heparin |
| SA171935 | - | CV_F_271020_5 | Facility2 | SPF | F | Polar | CV_F_271020_5 | 100 | - | Plasma + lithium heparin |
| SA171932 | - | CV_F_271020_6 | Facility2 | SPF | F | Polar | CV_F_271020_6 | 100 | - | Plasma + lithium heparin |
| SA171943 | - | CV_F_271020_7 | Facility2 | SPF | F | Polar | CV_F_271020_7 | 100 | - | Plasma + lithium heparin |
| SA171936 | - | CV_F_271020_8 | Facility2 | SPF | F | Polar | CV_F_271020_8 | 100 | - | Plasma + lithium heparin |
| SA171951 | - | CV_2M_231120_1_L | Facility2 | SPF | M | Lipids | CV_2M_231120_1_L | 100 | - | Plasma + lithium heparin |
| SA171944 | - | CV_2M_231120_2_L | Facility2 | SPF | M | Lipids | CV_2M_231120_2_L | 100 | - | Plasma + lithium heparin |
| SA171952 | - | CV_M_041120_1_L | Facility2 | SPF | M | Lipids | CV_M_041120_1_L | 100 | - | Plasma + lithium heparin |
| SA171953 | - | CV_M_041120_2_L | Facility2 | SPF | M | Lipids | CV_M_041120_2_L | 100 | - | Plasma + lithium heparin |
| SA171954 | - | CV_M_041120_3_L | Facility2 | SPF | M | Lipids | CV_M_041120_3_L | 100 | - | Plasma + lithium heparin |
| SA171950 | - | CV_M_041120_4_L | Facility2 | SPF | M | Lipids | CV_M_041120_4_L | 100 | - | Plasma + lithium heparin |
| SA171949 | - | CV_M_271020_1_L | Facility2 | SPF | M | Lipids | CV_M_271020_1_L | 100 | - | Plasma + lithium heparin |
| SA171945 | - | CV_M_271020_2_L | Facility2 | SPF | M | Lipids | CV_M_271020_2_L | 47,6 | hemolyse low volume | Plasma + lithium heparin |
| SA171946 | - | CV_M_271020_3_L | Facility2 | SPF | M | Lipids | CV_M_271020_3_L | 100 | - | Plasma + lithium heparin |
| SA171947 | - | CV_M_271020_4_L | Facility2 | SPF | M | Lipids | CV_M_271020_4_L | 100 | - | Plasma + lithium heparin |
| SA171948 | - | CV_M_271020_5_L | Facility2 | SPF | M | Lipids | CV_M_271020_5_L | 100 | - | Plasma + lithium heparin |
| SA171955 | - | CV_M_271020_6_L | Facility2 | SPF | M | Lipids | CV_M_271020_6_L | 100 | - | Plasma + lithium heparin |
| SA171956 | - | CV_2M_231120_1 | Facility2 | SPF | M | Polar | CV_2M_231120_1 | 100 | - | Plasma + lithium heparin |
| SA171963 | - | CV_2M_231120_2 | Facility2 | SPF | M | Polar | CV_2M_231120_2 | 100 | - | Plasma + lithium heparin |
| SA171964 | - | CV_M_041120_1 | Facility2 | SPF | M | Polar | CV_M_041120_1 | 100 | - | Plasma + lithium heparin |
| SA171965 | - | CV_M_041120_2 | Facility2 | SPF | M | Polar | CV_M_041120_2 | 100 | - | Plasma + lithium heparin |
| SA171966 | - | CV_M_041120_3 | Facility2 | SPF | M | Polar | CV_M_041120_3 | 100 | - | Plasma + lithium heparin |
| SA171962 | - | CV_M_041120_4 | Facility2 | SPF | M | Polar | CV_M_041120_4 | 100 | - | Plasma + lithium heparin |
| SA171961 | - | CV_M_271020_1 | Facility2 | SPF | M | Polar | CV_M_271020_1 | 100 | - | Plasma + lithium heparin |
| SA171957 | - | CV_M_271020_2 | Facility2 | SPF | M | Polar | CV_M_271020_2 | 47,6 | hemolyse low volume | Plasma + lithium heparin |
| SA171958 | - | CV_M_271020_3 | Facility2 | SPF | M | Polar | CV_M_271020_3 | 100 | - | Plasma + lithium heparin |
| SA171959 | - | CV_M_271020_4 | Facility2 | SPF | M | Polar | CV_M_271020_4 | 100 | - | Plasma + lithium heparin |
| SA171960 | - | CV_M_271020_5 | Facility2 | SPF | M | Polar | CV_M_271020_5 | 100 | - | Plasma + lithium heparin |
| SA171967 | - | CV_M_271020_6 | Facility2 | SPF | M | Polar | CV_M_271020_6 | 100 | - | Plasma + lithium heparin |
